Re: re QURE's HemoB trial (news from 6/22)
good find. I'm not sure the market hasn't already expected it will take more than 12-month of data to file. 1.5 years is probably as good as could be expected and seems like a reasonable decision by FDA. SGMO's GT seems to start acting fast, but how long until patients reach steady state?